Mindfulness and HEP in Dialysis Patients With Depression and Anxiety
Renal Disease, Depression, Anxiety
About this trial
This is an interventional treatment trial for Renal Disease
Eligibility Criteria
Inclusion Criteria:
- Aged 18yrs.>
- Currently receiving maintenance hemodialysis, with depression (Patient Health Questionnaire (PHQ-9) score ≥6) and/or anxiety (General Anxiety Disorder-7 (GAD- 7) score ≥6).
- Normal cognition or Mild Cognitive Impairment will be addressed on a normal screening result on the 3-minute Mini-Cog Test (53).
- Patients should have sufficient hearing to follow verbal instructions, be able to sit for 20-25 minutes without discomfort
- Have adequate understanding of English and/or French
Exclusion Criteria:
- Mild, Moderate, or Severe Dementia ("Abnormal" Result on the 3-minute Mini-Cog Test (53))
- Acute psychotic symptoms,
- Acute suicidal ideation/intent
- Patients currently receiving active psychotherapy
Sites / Locations
- Lady David Institute
- McGill University Health Centre
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Chair-side mindfulness intervention
Health Enhancement Plan (HEP)
Consists of individually conducted meditative practices, lasting 20 minutes/session, 3 times per week for 8 weeks. The interventions will be conducted during their dialysis sessions. The mindfulness meditation sessions include well-described meditations such as the body scan (being aware of bodily sensation), gentle arm movements, guided and silent breath meditations.
Has been previously designed and used for the purpose of being a manualized active control in meditation-based intervention trials, controlling for several non-specific factors found in a mindfulness meditation group. Participants will learn about health promotion, healthy diet, music, exercise as well as implementing positive health-enhancing life changes both in-session and during at-home practice with the support of a group facilitator, but do not learn mindfulness techniques.